The present invention provides a substance which inhibits the binding between E2/NS1 protein of hepatitis C virus and a cell infectious with hepatitis C virus, a cell expressing CD81, or CD81. The present invention can provide a novel medicament which has an anti-viral effects such as an inhibitory action against HCV infection.

 
Web www.patentalert.com

< Specific and sensitive nucleic acid detection method

< Self-replicating RNA molecule from hepatitis C virus

> Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use

> Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes
~ 00294